Trials / Completed
CompletedNCT01429285
Safety and Efficacy of Intravenous Hydromorphone in Elderly Emergency Department Patients With Acute Severe Pain
Safety and Efficacy of Intravenous Hydromorphone Using Incremental Doses of 0.5 mg in Elderly ED Patients With Acute Severe Pain
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 350 (actual)
- Sponsor
- Montefiore Medical Center · Academic / Other
- Sex
- All
- Age
- 65 Years – 120 Years
- Healthy volunteers
- Accepted
Summary
The hydromorphone protocol is more effective than usual care in Emergency Department (ED) patients age 65 years and older in terms of proportion who choose to forgo additional pain medication within 60 minutes post-baseline in the two groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hydromorphone | 0.5 mg IV hydromorphone followed by an optional 0.5 mg IV dose |
| DRUG | Usual care | Attending administers any IV opioid in any dose he chooses |
Timeline
- Start date
- 2009-07-01
- Primary completion
- 2012-06-01
- Completion
- 2012-06-01
- First posted
- 2011-09-07
- Last updated
- 2018-05-18
- Results posted
- 2018-04-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01429285. Inclusion in this directory is not an endorsement.